NCT00139854View on ClinicalTrials.gov

A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2004

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
ANXIETY
Interventions
DRUG

Alprazolam orally disintegrating tablets

Trial Locations (1)

Unknown

Schwarz, Milwaukee

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY